基本信息
浏览量:1
职业迁徙
个人简介
Edwin Trevathan, M.D., M.P.H. is the Amos Christie Chair in Global Health and Professor of Pediatrics and Neurology at Vanderbilt University Medical Center. Prior to assuming his current position at Vanderbilt, Dr. Trevathan served in a several leadership positions, including Professor (Neuroscience), Executive Vice President & Provost at Baylor University, Professor (Epidemiology, Neurology & Pediatrics) and Dean of the College for Public Health and Social Justice at Saint Louis University (SLU), Director of the National Center on Birth Defects and Developmental Disabilities at the U.S. Centers for Disease Control and Prevention (CDC), and Professor and Director of the Division of Pediatric Neurology at Washington University in St. Louis. A pediatric neurologist and epidemiologist, Dr. Trevathan's research interests include maternal-child epidemiology, epidemiology of childhood neurological disorders and clinical trials of treatments of neurological disorders. His research and practice has focused on global health.
Dr. Trevathan is the PI/PD for two major NIH-funded projects in Africa. Bridging the Childhood Epilepsy Treatment Gap in sub-Saharan Africa (BRIDGE; R21 TW010899, R01 NS113171 ) is a .five-year (2019-2024) project that includes a 60-site cluster randomized clinical trial of task-shifted epilepsy care (to community health workers) in three northern Nigerian cities (Kano, Zaria, and Kaduna). BRIDGE is the first major cluster randomized clinical trial of task-shifted epilepsy care, and the results will have an impact on policies designed to reduce the epilepsy treatment gap. Childhood Status Epilepticus and Epilepsy Determinants of Outcome (SEED-1; R01 NS118483) is a large five year (2020-2025) cohort of childhood status epilepticus (SE) in Kano, Nigeria. SEED-1 will enroll about 1500 children with SE, with deep phenotyping of childhood SE, clinical determinants of short-term and long-term outcomes, and genomic components of short-term and long-term outcomes. Clinical and genomic predictors of benzodiazepine resistent SE will be studied. Clinical and genomic predictors of the development of epilepsy among children who survive SE as their first seizure will also be determined. Trevathan is also the Multi-PI/Program Director for "Developing Future Leaders in Child Neurology and Epilepsy Research" funding by NIH (D43 TW011949).
While a member of the senior leadership team at CDC, he was responsible for many of the CDC’s activities in areas of child health and development, neurological disorders, maternal and child health, genetics, blood disorders, birth defects and developmental disabilities. Under his leadership, the CDC engaged in several productive collaborations in China, Latin America and Africa. While at CDC Dr. Trevathan also served as the Strategic Lead for the pediatric response to the 2009 H1N1 flu worldwide epidemic. As dean at SLU he led a significant expansion of the school that led to a doubling of the number of faculty, and a reorganization resulting in the formation of a new college - SLU's College for Public Health and Social Justice.
Trevathan has served on a variety of U.S. national committees such as the Federal Advisory Committee of the National Children’s Study, the Autism Interagency Coordinating Committee, and various committees of the Institute of Medicine and of the World Health Organization. His global health experience includes work in China, Nigeria, Honduras, Uganda, and Democratic Republic of Congo. He served as a member of the NINDS/NIH Advisory Council (2019-2023).
Dr. Trevathan received his B.S. (Chemistry) from Lipscomb University, and his M.D. and M.P.H. from Emory University, where he was elected to Alpha Omega Alpha. He was a resident in pediatrics at Yale, and in neurology and child neurology at Massachusetts General Hospital and Harvard. He was a fellow in clinical neurophysiology at Boston Children’s Hospital. Dr. Trevathan has authored or co-authored over 100 clinical and scientific publications. He serves on several editorial boards, and lectures nationally and internationally.
研究兴趣
论文共 134 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
A. T. Abdullahi, U. Sabo, H. Ahmad, F. Nuhu,H. Adamu, L. Habiba, A. Ibrahim, J. Sani, I. Abdulakir, S. Ibrahim, F. Olugbenga, As Salihu,
EPILEPSIA (2023): 102-103
引用0浏览0引用
0
0
Neurologyno. 7 Suppl 1 (2023): S1-S8
EPILEPSIA (2023): 569-570
引用0浏览0引用
0
0
American Public Health Association eBooks (2023)
引用0浏览0引用
0
0
Neurologyno. 7 Suppl 1 (2023): S9-S16
E. Trevathan, M. Umar, A. T. Abdullahi, A. O. Kalu, H. B. Salihu, H. Yakubu,U. Ibrahim, A. A. Yakubu, J. S. Anate, H. Ahmad, F. Nuhu, A. S. Salihu,
EPILEPSIA (2023): 535-536
引用0浏览0引用
0
0
引用0浏览0引用
0
0
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn